Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-infiltrating lymphocytes and CD8+ T cells predict survival of triple-negative breast cancer
H. Vihervuori, Tuomo-Artturi Autere, Heli Repo, et al.
Journal of Cancer Research and Clinical Oncology (2019) Vol. 145, Iss. 12, pp. 3105-3114
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Cancer-Associated Fibroblasts Suppress CD8+ T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade
Liam Jenkins, Ute Jungwirth, Alexandra Avgustinova, et al.
Cancer Research (2022) Vol. 82, Iss. 16, pp. 2904-2917
Open Access | Times Cited: 142
Highly Multiplexed Immunohistochemical MALDI-MS Imaging of Biomarkers in Tissues
Gargey Yagnik, Ziying Liu, Kenneth J. Rothschild, et al.
Journal of the American Society for Mass Spectrometry (2021) Vol. 32, Iss. 4, pp. 977-988
Open Access | Times Cited: 100
The interactions of paclitaxel with tumour microenvironment
Ding‐Li Yu, Zhiping Lou, Fengyun Ma, et al.
International Immunopharmacology (2022) Vol. 105, pp. 108555-108555
Closed Access | Times Cited: 67
PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers
Linjie Luo, Khandan Keyomarsi
Expert Opinion on Investigational Drugs (2022) Vol. 31, Iss. 6, pp. 607-631
Open Access | Times Cited: 47
The Impact of Exercise on Immunity, Metabolism, and Atherosclerosis
Ulrike Meyer-Lindemann, Aldo Moggio, Alexander Dutsch, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3394-3394
Open Access | Times Cited: 24
Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
Hongmei Zheng, Sumit Siddharth, Sheetal Parida, et al.
Cancers (2021) Vol. 13, Iss. 13, pp. 3357-3357
Open Access | Times Cited: 56
Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors
Emre Balta, Guido H. Wabnitz, Yvonne Samstag
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 11, pp. 5736-5736
Open Access | Times Cited: 50
Immunotherapy in triple-negative breast cancer: Insights into tumor immune landscape and therapeutic opportunities
Rita Ribeiro, Maria João Carvalho, João Gonçalves, et al.
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 36
Prospects of Immunotherapy for Triple-Negative Breast Cancer
Dan Qiu, Guijuan Zhang, Xianxin Yan, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 30
Osteoclast-derived apoptotic bodies inhibit naive CD8+ T cell activation via Siglec15, promoting breast cancer secondary metastasis
Yutong Wu, Hongbo Ai, Yuhang Xi, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 9, pp. 101165-101165
Open Access | Times Cited: 19
Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
Li Yang, Wenfang Miao, Doudou He, et al.
Frontiers in Bioengineering and Biotechnology (2021) Vol. 9
Open Access | Times Cited: 38
Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer
Aalok Patwa, Rikiya Yamashita, Jin Long, et al.
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 38
Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
Hongwei Yu, Xianqi Meng, Huang Chen, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 35
Triple-Negative Breast Cancer: Intact Mismatch Repair and Partial Co-Expression of PD-L1 and LAG-3
Shafei Wu, Xiaohua Shi, Jing Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 29
Evaluating Tumor‐Infiltrating Lymphocytes in Breast Cancer Using Preoperative MRI‐Based Radiomics
Tiantian Bian, Zengjie Wu, Qing Lin, et al.
Journal of Magnetic Resonance Imaging (2021) Vol. 55, Iss. 3, pp. 772-784
Closed Access | Times Cited: 28
A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer
Weibin Lian, Peidong Yang, Liangqiang Li, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 13
Prognostic value of various immune cells and Immunoscore in triple-negative breast cancer
Xinyu Ren, Yu Song, Junyi Pang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Systemic infusion of TLR3-ligand and IFN-α in patients with breast cancer reprograms local tumor microenvironments for selective CTL influx
Shipra Gandhi, Mateusz Opyrchal, Melissa Grimm, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007381-e007381
Open Access | Times Cited: 11
TME-analyzer: a new interactive and dynamic image analysis tool that identified immune cell distances as predictors for survival of triple negative breast cancer patients
Hayri E. Balcıoğlu, Rebecca Wijers, Marcel Smid, et al.
npj Imaging (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 4
Immune Microenvironment in Breast Cancer Metastasis
Bin‐Zhi Qian, Ruoyu Ma
Advances in experimental medicine and biology (2025), pp. 413-432
Closed Access
The prognostic value of the tumor-stroma ratio compared to tumor-infiltrating lymphocytes in triple-negative breast cancer: a review
Layla Andour, Sophie C. Hagenaars, Barbara Gregus, et al.
Virchows Archiv (2025)
Open Access
ADAM17-mediated EGFR ligand shedding directs macrophage-promoted cancer cell invasion
Sebastian Gnosa, Laia Puig Blasco, Krzysztof B. Piotrowski, et al.
JCI Insight (2022) Vol. 7, Iss. 18
Open Access | Times Cited: 17
Prognostic significance of CD8 + tumor-infiltrating lymphocytes in operable breast cancer: a meta-analysis
Ruijie Niu, Cheng Wang, Yiqun Xie, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access
Predicting the Level of Tumor-Infiltrating Lymphocytes in Patients With Breast Cancer: Usefulness of Mammographic Radiomics Features
Hongwei Yu, Xianqi Meng, Huang Chen, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 23
A novel role for an old target: CD45 for breast cancer immunotherapy
Annat Raiter, Oran Zlotnik, Julia Lipovetsky, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 22
Page 1 - Next Page

Scroll to top